Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway

Trilobolide-6-O-isobutyrate exhibits significant antitumor effects on cholangiocarcinoma (CCA) cells by effectively inhibiting the JAK/STAT3 signaling pathway. This study aims to investigate the mechanisms underlying the antitumor properties of trilobolide-6-O-isobutyrate, and to explore its potenti...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hao-Xuan Zhang, Rui Fan, Qian-En Chen, Lin-Jun Zhang, Yang Hui, Peng Xu, Si-Yang Li, Guang-Ying Chen, Wen-Hao Chen, Dong-Yan Shen
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-03-01
Col·lecció:	Heliyon
Matèries:	TBB Cholangiocarcinoma Proliferation Apoptosis JAK/STAT pathway
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2405844024032481
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!